BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32474813)

  • 21. Supratentorial cortical ependymoma: A systematic literature review and case illustration.
    Cuoco JA; Strohman AC; Stopa BM; Stump MS; Entwistle JJ; Witcher MR; Olasunkanmi AL
    Rare Tumors; 2022; 14():20363613221112432. PubMed ID: 35836750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Verification of the diagnosis of supratentorial ependymomas by real-time PCR].
    Galstyan SA; Telysheva EN; Lavrinovich AO; Shaikhaev EG; Snigireva GP; Petrova EI; Gorelyshev SK; Zheludkova OG; Kushel YV; Kumirova EV; Ryzhova MV
    Arkh Patol; 2023; 85(3):5-11. PubMed ID: 37272434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
    Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
    Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
    Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
    Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
    Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
    PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
    Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
    Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
    Chapman RJ; Ghasemi DR; Andreiuolo F; Zschernack V; Espariat AT; Buttarelli FR; Giangaspero F; Grill J; Haberler C; Paine SML; Scott I; Jacques TS; Sill M; Pfister S; Kilday JP; Leblond P; Massimino M; Witt H; Modena P; Varlet P; Pietsch T; Grundy RG; Pajtler KW; Ritzmann TA
    Neuro Oncol; 2023 Oct; 25(10):1871-1882. PubMed ID: 36916248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
    Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
    Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
    Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal imbalances in clear cell ependymomas.
    Rickert CH; Korshunov A; Paulus W
    Mod Pathol; 2006 Jul; 19(7):958-62. PubMed ID: 16648869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
    Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
    Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study.
    Wang Q; Cheng J; Zhang S; Li Q; Hui X; Ju Y
    Neurosurg Rev; 2021 Jun; 44(3):1543-1551. PubMed ID: 32607870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
    Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
    Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic study of 33 ependymomas.
    Vagner-Capodano AM; Zattara-Cannoni H; Gambarelli D; Figarella-Branger D; Lena G; Dufour H; Grisoli F; Choux M
    Cancer Genet Cytogenet; 1999 Dec; 115(2):96-9. PubMed ID: 10598140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results of eight patients with intracranial ependymomas].
    Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
    No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
    Jenseit A; Camgöz A; Pfister SM; Kool M
    Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
    Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
    Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.